Maynard Um
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Lowered to $70 at BTIG
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
-
-
-
-
-
-
-
TD Cowen notes short interest shifts in life science tools stocks
-
-
-
-
-
-
-
Tempus AI to present 37 research abstracts at 2026 ASCO meeting
-
-
-
-
-
-
-
Tempus and Predicta partner on blood cancer genome testing assay
-
-
-
-
-
-
-
This company's core business is undervalued, Mizuho says
-
-
-
-
-
-
-
Tempus AI (TEM) call put ratio 1.1 calls to 1 put into updated guidance
-
447,253 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

